Poxvirus vectors: orphaned and underappreciated
Open Access
- 15 April 2000
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (8), 1031-1034
- https://doi.org/10.1172/jci9819
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Strategies in the development of recombinant vaccines for colon cancer.1999
- Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanomaCancer Gene Therapy, 1999
- Applications of pox virus vectors to vaccination: an update.Proceedings of the National Academy of Sciences, 1996
- Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.Proceedings of the National Academy of Sciences, 1996
- In situ cytokine gene transfection using vaccinia virus vectors.1996
- Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors.1994
- Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Proceedings of the National Academy of Sciences, 1993
- Nonreplicating vaccinia vector efficiently expresses recombinant genes.Proceedings of the National Academy of Sciences, 1992
- New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteinsNucleic Acids Research, 1990
- Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNAGene, 1983